Your browser doesn't support javascript.
loading
Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia?
Tsuang, Debby; Esterberg, Michelle; Braff, David; Calkins, Monica; Cadenhead, Kristin; Dobie, Dorcas; Freedman, Robert; Green, Michael F; Greenwood, Tiffany; Gur, Raquel; Gur, Ruben; Horan, William; Lazzeroni, Laura C; Light, Gregory A; Millard, Steven P; Olincy, Ann; Nuechterlein, Keith; Seidman, Larry; Siever, Larry; Silverman, Jeremy; Stone, William; Sprock, Joyce; Sugar, Catherine; Swerdlow, Neal; Tsuang, Ming; Turetsky, Bruce; Radant, Allen.
Afiliação
  • Tsuang D; VISN-20 Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, United States of America ; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, United States of America.
  • Esterberg M; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, United States of America.
  • Braff D; VISN-22 Mental Illness Research, Education, and Clinical Center, VA San Diego Healthcare System, San Diego, California, United States of America ; Department of Psychiatry, University of California San Diego, San Diego, California, United States of America.
  • Calkins M; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Cadenhead K; Department of Psychiatry, University of California San Diego, San Diego, California, United States of America.
  • Dobie D; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, United States of America ; VISN-20 Mental Illness Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, United States of America.
  • Freedman R; Department of Psychiatry, University of Colorado Health Sciences Center, Denver, Colorado, United States of America.
  • Green MF; Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America ; VA Greater Los Angeles Health Care System, Los Angeles, California, United States of America.
  • Greenwood T; Department of Psychiatry, University of California San Diego, San Diego, California, United States of America.
  • Gur R; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Gur R; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Horan W; Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America ; VA Greater Los Angeles Health Care System, Los Angeles, California, United States of America.
  • Lazzeroni LC; Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California, United States of America.
  • Light GA; VISN-22 Mental Illness Research, Education, and Clinical Center, VA San Diego Healthcare System, San Diego, California, United States of America ; Department of Psychiatry, University of California San Diego, San Diego, California, United States of America.
  • Millard SP; VISN-20 Mental Illness Research, Education, and Clinical Center, VA Puget Sound Health Care System, Seattle, Washington, United States of America.
  • Olincy A; Department of Psychiatry, University of Colorado Health Sciences Center, Denver, Colorado, United States of America.
  • Nuechterlein K; Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America.
  • Seidman L; Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Harvard Medical School Department of Psychiatry, Boston, Massachusetts, United States of America.
  • Siever L; Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, United States of America; VISN-3 Mental Illness Research, Education, and Clinical Center, James J. Peters VA Medical Center, New York, New York, United States of America.
  • Silverman J; Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, United States of America; VISN-3 Mental Illness Research, Education, and Clinical Center, James J. Peters VA Medical Center, New York, New York, United States of America.
  • Stone W; Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Harvard Medical School Department of Psychiatry, Boston, Massachusetts, United States of America.
  • Sprock J; Department of Psychiatry, University of California San Diego, San Diego, California, United States of America.
  • Sugar C; Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America ; VA Greater Los Angeles Health Care System, Los Angeles, California, United States of America.
  • Swerdlow N; Department of Psychiatry, University of California San Diego, San Diego, California, United States of America.
  • Tsuang M; Department of Psychiatry, University of California San Diego, San Diego, California, United States of America.
  • Turetsky B; Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Radant A; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, United States of America.
PLoS One ; 9(2): e88379, 2014.
Article em En | MEDLINE | ID: mdl-24523888
ABSTRACT
The children of older fathers have increased risks of developing schizophrenia spectrum disorders, and among those who develop these disorders, those with older fathers present with more severe clinical symptoms. However, the influence of advanced paternal age on other important domains related to schizophrenia, such as quantitative endophenotype deficit levels, remains unknown. This study investigated the associations between paternal age and level of endophenotypic impairment in a well-characterized family-based sample from the Consortium on the Genetics of Schizophrenia (COGS). All families included at least one affected subject and one unaffected sibling. Subjects met criteria for schizophrenia (probands; n = 293) or were unaffected first-degree siblings of those probands (n = 382). Paternal age at the time of subjects' birth was documented. Subjects completed a comprehensive clinical assessment and a battery of tests that measured 16 endophenotypes. After controlling for covariates, potential paternal age-endophenotype associations were analyzed using one model that included probands alone and a second model that included both probands and unaffected siblings. Endophenotype deficits in the Identical Pairs version of the 4-digit Continuous Performance Test and in the Penn Computerized Neurocognitive Battery verbal memory test showed significant associations with paternal age. However, after correcting for multiple comparisons, no endophenotype was significantly associated with paternal age. These findings suggest that factors other than advanced paternal age at birth may account for endophenotypic deficit levels in schizophrenia.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Idade Paterna / Endofenótipos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Idade Paterna / Endofenótipos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article